Characteristics of people living in Italy after a cancer diagnosis in 2010 and projections to 2020

Abstract

BackgroundEstimates of cancer prevalence are widely based on limited duration, often including patients living after a cancer diagnosis made in the previous 5 years and less frequently on complete prevalence (i.e., including all patients regardless of the time elapsed since diagnosis). This study aims to provide estimates of complete cancer prevalence in Italy by sex, age, and time since diagnosis for all cancers combined, and for selected cancer types. Projections were made up to 2020, overall and by time since diagnosis.MethodsData were from 27 Italian population-based cancer registries, covering 32% of the Italian population, able to provide at least 7 years of registration as of December 2009 and follow-up of vital status as of December 2013. The data were used to compute the limited-duration prevalence, in order to estimate the complete prevalence by means of the COMPREV software.ResultsIn 2010, 2,637,975 persons were estimated to live in Italy after a cancer diagnosis, 1.2 million men and 1.4 million women, or 4.6% of the Italian population. A quarter of male prevalent cases had prostate cancer (n = 305,044), while 42% of prevalent women had breast cancer (n = 604,841). More than 1.5 million people (2.7% of Italians) were alive since 5 or more years after diagnosis and 20% since ≥15 years. It is projected that, in 2020 in Italy, there will be 3.6 million prevalent cancer cases (+ 37% vs 2010). The largest 10-year increases are foreseen for prostate (+ 85%) and for thyroid cancers (+ 79%), and for long-term survivors diagnosed since 20 or more years (+ 45%). Among the population aged ≥75 years, 22% will have had a previous cancer diagnosis.ConclusionsThe number of persons living after a cancer diagnosis is estimated to rise of approximately 3% per year in Italy. The availability of detailed estimates and projections of the complete prevalence are intended to help the implementation of guidelines aimed to enhance the long-term follow-up of cancer survivors and to contribute their rehabilitation needs.

Cancer survivorship: an integral part of Europe's research agenda

“…To date, about half of patients who are diagnosed with cancer will survive for 10 years or more (Allemani et al, 2018;Cancer Research UK, 2017, De Angelis et al, 2014. The proportion of people predicted to survive a diagnosis of cancer is increasing by~3% per year (Guzzinati et al, 2018). An increasing prevalence of individuals with long-term chronic health problems and comorbidity will require a healthcare system, which can accommodate their growing need for long-term follow-up, good quality of life and functioning, returning to work, living independently and a reduction of cancer recurrence.…”

Vegetable and Fruit Consumption and Prognosis Among Cancer Survivors: A Systematic Review and Meta-Analysis of Cohort Studies

“…In parallel, advances in early detection, treatment, and supportive care have led to a rapid and steady rise in the number of cancer survivors worldwide ( 2 ). The amount of people predicted to survive a diagnosis of cancer is increasing by ∼3% per year ( 3 ), the majority now surviving 5 y or more ( 4 ). Indeed, in 2011, 50% of UK cancer patients had a 10-y survival rate ( 5 ).…”

Major patterns of cancer cure: Clinical implications

“…The number of people living after a cancer diagnosis has been consistently increasing in recent years, reaching approximately 5% of the overall population in several countries (De Moor et al, 2013;Guzzinati et al, 2018;Hovaldt et al, 2015;Maddams, Utley, & Møller, 2012). This trend is mainly driven by the increasing number of new cancer diagnoses due to the population ageing and to an improved survival associated with enhanced treatments and early diagnosis.…”